MILTON M HOM
- Type
- Physician · Eye and Vision Services Providers / Optometrist / Corneal and Contact Management
- Where
- AZUSA, CA
- NPI
- 1326158478
- Received
- $1,329,705 in 533 records, 2019 to 2025 ($762,340 general, $567,365 research)
- As principal investigator
- $236,383 of research payments to others in 33 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 60 | $36,372 |
| 2024 | General payment | 49 | $9,119 |
| 2024 | Research payment | 1 | $22,342 |
| 2023 | General payment | 59 | $347,208 |
| 2023 | Research payment | 5 | $135,651 |
| 2022 | General payment | 95 | $93,245 |
| 2021 | General payment | 66 | $84,743 |
| 2021 | Research payment | 9 | $38,636 |
| 2020 | General payment | 67 | $37,195 |
| 2020 | Research payment | 7 | $36,934 |
| 2019 | General payment | 103 | $154,455 |
| 2019 | Research payment | 12 | $333,801 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Allergan, Inc. | 122 | $454,803 | 2019–2022 |
| Bausch & Lomb Americas Inc. | 37 | $395,222 | 2022–2025 |
| ABBVIE INC. | 82 | $202,328 | 2021–2025 |
| Bausch & Lomb, a division of Bausch Health US, LLC | 71 | $170,016 | 2019–2021 |
| Shire North American Group Inc | 13 | $44,109 | 2019 |
| Harrow Eye, LLC | 24 | $26,029 | 2025 |
| Bausch Health US, LLC | 2 | $17,000 | 2019 |
| Novartis Pharmaceuticals Corporation | 31 | $4,610 | 2019–2023 |
| Thea Pharma Inc. | 12 | $2,410 | 2022–2025 |
| Dompe US, Inc. | 1 | $2,400 | 2023 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 98 | $2,132 | 2019–2025 |
| Oyster Point Pharma, Inc. | 4 | $1,821 | 2023–2024 |
| Eyevance Pharmaceuticals LLC | 3 | $1,539 | 2019–2020 |
| TOPCON HEALTHCARE, INC. | 1 | $1,500 | 2019 |
| Carl Zeiss Meditec, Inc. | 4 | $1,305 | 2019–2022 |
| Alcon Vision LLC | 7 | $1,195 | 2022–2024 |
| Kala Pharmaceuticals, Inc. | 14 | $1,055 | 2019–2022 |
| Tarsus Pharmaceuticals, Inc. | 5 | $146 | 2024–2025 |
| Mallinckrodt Enterprises LLC | 1 | $37 | 2019 |
| Aerie Pharmaceuticals, Inc. | 1 | $37 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 34 | $567,365 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 32 | $348,512 |
| Consulting Fee | 87 | $208,571 |
| Compensation for serving as faculty or as a speaker for a medical education program | 6 | $74,262 |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing | 4 | $72,800 |
| Education | 2 | $32,500 |
| Food and Beverage | 317 | $10,007 |
| Travel and Lodging | 47 | $8,469 |
| Honoraria | 3 | $7,200 |
| Gift | 1 | $17 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | Harrow Eye, LLC | $2,200 | Consulting Fee | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-12-20 | Harrow Eye, LLC | $9 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-12-20 | Harrow Eye, LLC | $2 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-12-18 | SUN PHARMACEUTICAL INDUSTRIES INC. | $13 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-12-17 | Harrow Eye, LLC | $32 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-12-11 | ABBVIE INC. | $1,800 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-04 | ABBVIE INC. | $437 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-04 | SUN PHARMACEUTICAL INDUSTRIES INC. | $16 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-11-27 | Harrow Eye, LLC | $13 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-11-19 | Harrow Eye, LLC | $6,100 | Honoraria | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-11-19 | Harrow Eye, LLC | $658 | Travel and Lodging | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-11-19 | Harrow Eye, LLC | $624 | Travel and Lodging | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-11-19 | Harrow Eye, LLC | $296 | Travel and Lodging | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-11-19 | Harrow Eye, LLC | $125 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-11-14 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-11-13 | ABBVIE INC. | $5,250 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-29 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-10-21 | ABBVIE INC. | $875 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-20 | ABBVIE INC. | $875 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-15 | Harrow Eye, LLC | $10 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-10-12 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-10-11 | Harrow Eye, LLC | $105 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-10-11 | Thea Pharma Inc. | $89 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-10 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-08 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-08 | Harrow Eye, LLC | $99 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-10-08 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-29 | Harrow Eye, LLC | $8,100 | Consulting Fee | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-09-29 | Harrow Eye, LLC | $500 | Consulting Fee | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-09-25 | SUN PHARMACEUTICAL INDUSTRIES INC. | $16 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-09-21 | Harrow Eye, LLC | $182 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-09-18 | ABBVIE INC. | $59 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Thea Pharma Inc. | $64 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-16 | Bausch & Lomb Americas Inc. | $14 | Food and Beverage | In-kind items and services | XIIDRA Drug, Ophthalmology | 2025 | |
| 2025-08-22 | SUN PHARMACEUTICAL INDUSTRIES INC. | $16 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-08-08 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-07-25 | SUN PHARMACEUTICAL INDUSTRIES INC. | $14 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-06-29 | Harrow Eye, LLC | $597 | Travel and Lodging | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-06-29 | Harrow Eye, LLC | $141 | Travel and Lodging | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-06-29 | Harrow Eye, LLC | $90 | Food and Beverage | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-06-26 | ABBVIE INC. | $37 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-04 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-05-30 | Harrow Eye, LLC | $6,000 | Consulting Fee | Cash or cash equivalent | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-05-23 | SUN PHARMACEUTICAL INDUSTRIES INC. | $14 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-05-21 | Harrow Eye, LLC | $48 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-05-21 | Harrow Eye, LLC | $23 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-05-07 | Thea Pharma Inc. | $71 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-29 | Thea Pharma Inc. | $97 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-23 | SUN PHARMACEUTICAL INDUSTRIES INC. | $14 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-04-23 | Harrow Eye, LLC | $8 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-04-08 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-03-19 | SUN PHARMACEUTICAL INDUSTRIES INC. | $14 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-03-14 | Tarsus Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-03-07 | SUN PHARMACEUTICAL INDUSTRIES INC. | $11 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-02-27 | Harrow Eye, LLC | $57 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-26 | ABBVIE INC. | $109 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-19 | ABBVIE INC. | $70 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-19 | SUN PHARMACEUTICAL INDUSTRIES INC. | $46 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-02-06 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-01-10 | SUN PHARMACEUTICAL INDUSTRIES INC. | $13 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2024-12-20 | SUN PHARMACEUTICAL INDUSTRIES INC. | $9 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-12-06 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-11-15 | SUN PHARMACEUTICAL INDUSTRIES INC. | $12 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-11-08 | ABBVIE INC. | $92 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-07 | Alcon Vision LLC | $76 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-07 | SUN PHARMACEUTICAL INDUSTRIES INC. | $66 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-06 | ABBVIE INC. | $54 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-06 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2024 | |
| 2024-10-15 | SUN PHARMACEUTICAL INDUSTRIES INC. | $12 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-10-02 | ABBVIE INC. | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-10-02 | SUN PHARMACEUTICAL INDUSTRIES INC. | $14 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-09-20 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-19 | SUN PHARMACEUTICAL INDUSTRIES INC. | $100 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-19 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2024 | |
| 2024-09-18 | Thea Pharma Inc. | $51 | Food and Beverage | In-kind items and services | IYUZEH Drug, OPHTHALMOLOGY | 2024 | |
| 2024-09-05 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-08-20 | ABBVIE INC. | $3,600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-08-16 | SUN PHARMACEUTICAL INDUSTRIES INC. | $18 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-08-01 | SUN PHARMACEUTICAL INDUSTRIES INC. | $10 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-07-29 | Bausch & Lomb Americas Inc. | $60 | Food and Beverage | In-kind items and services | LOTEMAX SM Drug, Ophthalmology | 2024 | |
| 2024-07-25 | Oyster Point Pharma, Inc. | $13 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2024 | |
| 2024-07-18 | SUN PHARMACEUTICAL INDUSTRIES INC. | $9 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-07-17 | Tarsus Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2024 | |
| 2024-06-07 | SUN PHARMACEUTICAL INDUSTRIES INC. | $15 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-05-28 | Bausch & Lomb Americas Inc. | $104 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-23 | Alcon Vision LLC | $11 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2024 | |
| 2024-05-17 | SUN PHARMACEUTICAL INDUSTRIES INC. | $13 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-05-16 | Oyster Point Pharma, Inc. | $16 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2024 | |
| 2024-05-07 | ABBVIE INC. | $89 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-04 | ABBVIE INC. | $35 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-01 | ABBVIE INC. | $1,200 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-05-01 | ABBVIE INC. | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-04-30 | ABBVIE INC. | $1,050 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-04-12 | Alcon Vision LLC | $13 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2024 | |
| 2024-04-10 | SUN PHARMACEUTICAL INDUSTRIES INC. | $13 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-03-20 | ABBVIE INC. | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-03-14 | ABBVIE INC. | $70 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-07 | Alcon Vision LLC | $10 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2024 | |
| 2024-03-06 | SUN PHARMACEUTICAL INDUSTRIES INC. | $12 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-03-04 | Thea Pharma Inc. | $116 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-29 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-27 | Tarsus Pharmaceuticals, Inc. | $79 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-27 | Tarsus Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-09 | ABBVIE INC. | $38 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-09 | Alcon Vision LLC | $9 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2024 | |
| 2024-01-17 | SUN PHARMACEUTICAL INDUSTRIES INC. | $28 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2024-01-15 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2024 | |
| 2024-01-12 | Alcon Vision LLC | $14 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2024 | |
| 2024-01-11 | ABBVIE INC. | $22,342 | Research payment | Cash or cash equivalent | A patient experience study for temporary relief of burning, irritation, and discomfort due to dryness of the eye and ocu | 2024 | |
| 2024-01-05 | SUN PHARMACEUTICAL INDUSTRIES INC. | $8 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2024 | |
| 2023-12-12 | Bausch & Lomb Americas Inc. | $2,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2023 | |
| 2023-12-06 | SUN PHARMACEUTICAL INDUSTRIES INC. | $8 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-11-17 | Oyster Point Pharma, Inc. | $1,700 | Consulting Fee | Cash or cash equivalent | TYRVAYA Drug, DRY EYE | 2023 | |
| 2023-11-17 | Bausch & Lomb Americas Inc. | $23 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2023 | |
| 2023-11-08 | ABBVIE INC. | $9,724 | Research payment | Cash or cash equivalent | A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability | 2023 | |
| 2023-11-07 | ABBVIE INC. | $44,480 | Research payment | Cash or cash equivalent | A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability | 2023 | |
| 2023-11-07 | ABBVIE INC. | $37,761 | Research payment | Cash or cash equivalent | A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability | 2023 | |
| 2023-11-07 | ABBVIE INC. | $24,367 | Research payment | Cash or cash equivalent | A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability | 2023 | |
| 2023-11-07 | ABBVIE INC. | $19,319 | Research payment | Cash or cash equivalent | A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability | 2023 | |
| 2023-10-31 | Bausch & Lomb Americas Inc. | $90 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2023 | |
| 2023-10-24 | ABBVIE INC. | $1,200 | Consulting Fee | Cash or cash equivalent | VUITY Drug, EYE CARE | 2023 | |
| 2023-10-20 | SUN PHARMACEUTICAL INDUSTRIES INC. | $13 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-10-17 | Bausch & Lomb Americas Inc. | $62 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2023 | |
| 2023-10-12 | SUN PHARMACEUTICAL INDUSTRIES INC. | $9 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-10-11 | ABBVIE INC. | $39 | Food and Beverage | In-kind items and services | VUITY Drug, EYE CARE | 2023 | |
| 2023-10-11 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-10-10 | Thea Pharma Inc. | $98 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-10-04 | SUN PHARMACEUTICAL INDUSTRIES INC. | $9 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-09-28 | Oyster Point Pharma, Inc. | $91 | Food and Beverage | In-kind items and services | TYRVAYA Drug, DRY EYE | 2023 | |
| 2023-09-28 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VUITY Drug, EYE CARE | 2023 | |
| 2023-09-28 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VUITY Drug, EYE CARE | 2023 | |
| 2023-09-15 | SUN PHARMACEUTICAL INDUSTRIES INC. | $8 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-08-25 | Dompe US, Inc. | $2,400 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-08-23 | SUN PHARMACEUTICAL INDUSTRIES INC. | $9 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-08-15 | Bausch & Lomb Americas Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2023 | |
| 2023-08-10 | SUN PHARMACEUTICAL INDUSTRIES INC. | $11 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-07-27 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-06-29 | SUN PHARMACEUTICAL INDUSTRIES INC. | $7 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-06-15 | SUN PHARMACEUTICAL INDUSTRIES INC. | $11 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-06-02 | Bausch & Lomb Americas Inc. | $4,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | 2023 | ||
| 2023-06-02 | Bausch & Lomb Americas Inc. | $178 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-06-02 | Bausch & Lomb Americas Inc. | $174 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-06-02 | Bausch & Lomb Americas Inc. | $78 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-06-02 | Bausch & Lomb Americas Inc. | $51 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-31 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-05-23 | ABBVIE INC. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUITY Drug, EYE CARE | 2023 | |
| 2023-05-18 | Bausch & Lomb Americas Inc. | $22,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOTEMAX SM Drug, Ophthalmology | 2023 | |
| 2023-05-17 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-05-11 | Bausch & Lomb Americas Inc. | $76 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-05 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-04-21 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-04-13 | Bausch & Lomb Americas Inc. | $661 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-04-06 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-04-04 | ABBVIE INC. | $1,050 | Consulting Fee | Cash or cash equivalent | VUITY Drug, EYE CARE | 2023 | |
| 2023-03-29 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | XIIDRA Drug, Ophthalmology | 2023 | |
| 2023-03-24 | SUN PHARMACEUTICAL INDUSTRIES INC. | $5 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-03-18 | ABBVIE INC. | $71 | Food and Beverage | In-kind items and services | VUITY Drug, EYE CARE | 2023 | |
| 2023-03-17 | Thea Pharma Inc. | $30 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-03-14 | ABBVIE INC. | $600 | Consulting Fee | Cash or cash equivalent | VUITY Drug, EYE CARE | 2023 | |
| 2023-03-10 | SUN PHARMACEUTICAL INDUSTRIES INC. | $5 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-03-01 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VUITY Drug, EYE CARE | 2023 | |
| 2023-01-25 | SUN PHARMACEUTICAL INDUSTRIES INC. | $5 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $58,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $49,500 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | VYZULTA Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $28,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $25,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOTEMAX SM Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $25,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOTEMAX SM Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $22,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOTEMAX SM Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $22,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOTEMAX SM Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $17,500 | Education | In-kind items and services | 2023 | ||
| 2023-01-17 | Bausch & Lomb Americas Inc. | $16,500 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | VYZULTA Drug, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $15,000 | Education | In-kind items and services | 2023 | ||
| 2023-01-17 | Bausch & Lomb Americas Inc. | $14,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Boston 7 Device, Ophthalmology | 2023 | |
| 2023-01-17 | Bausch & Lomb Americas Inc. | $10,000 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2022-12-14 | SUN PHARMACEUTICAL INDUSTRIES INC. | $8 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2022 | |
| 2022-12-12 | ABBVIE INC. | $300 | Consulting Fee | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-12-08 | Carl Zeiss Meditec, Inc. | $1,050 | Consulting Fee | Cash or cash equivalent | VisuMax Device, Surgical Optical Laser | 2022 | |
| 2022-11-30 | Bausch & Lomb Americas Inc. | $2,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | 2022 | ||
| 2022-11-22 | SUN PHARMACEUTICAL INDUSTRIES INC. | $4 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2022 | |
| 2022-11-17 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2022 | |
| 2022-11-16 | Bausch & Lomb Americas Inc. | $500 | Consulting Fee | Cash or cash equivalent | LOTEMAX SM Drug, Ophthalmology | 2022 | |
| 2022-11-15 | Bausch & Lomb Americas Inc. | $114 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-09 | ABBVIE INC. | $1,350 | Consulting Fee | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-11-09 | Bausch & Lomb Americas Inc. | $45 | Food and Beverage | In-kind items and services | LOTEMAX SM Drug, Ophthalmology | 2022 | |
| 2022-11-04 | ABBVIE INC. | $300 | Consulting Fee | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-11-02 | SUN PHARMACEUTICAL INDUSTRIES INC. | $5 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2022 | |
| 2022-10-28 | ABBVIE INC. | $1,500 | Consulting Fee | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-10-28 | ABBVIE INC. | $600 | Consulting Fee | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-10-28 | Carl Zeiss Meditec, Inc. | $182 | Food and Beverage | In-kind items and services | VisuMax Device, Surgical Optical Laser | 2022 | |
| 2022-10-28 | ABBVIE INC. | $36 | Food and Beverage | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-10-26 | Thea Pharma Inc. | $80 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-10-18 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2022 | |
| 2022-10-10 | Thea Pharma Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-10-06 | SUN PHARMACEUTICAL INDUSTRIES INC. | $7 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2022 | |
| 2022-09-22 | ABBVIE INC. | $1,200 | Consulting Fee | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-09-22 | ABBVIE INC. | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUITY Drug, OPHTHALMOLOGY | 2022 | |
| 2022-09-21 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2022 | |
| 2022-09-16 | ABBVIE INC. | $86 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-09-15 | Thea Pharma Inc. | $104 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-09-14 | Thea Pharma Inc. | $105 | Food and Beverage | In-kind items and services | 2022 |
The latest 200 records of 533.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2024-11-07 | ABBVIE INC. | MILTON M HOM OD FAAO | $7,793 | A Multicenter, Double-masked, Randomized Study to Compare the Efficacy and Safety of the ABBV-444 Tear Formulation with | 2024 |
| 2024-07-30 | ABBVIE INC. | MILTON M HOM OD FAAO | $1,342 | A patient experience study for temporary relief of burning, irritation and discomfort due to dry eye | 2024 |
| 2021-12-31 | Allergan, Inc. | MILTON M HOM OD FAAO | $134 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2021 |
| 2021-04-23 | Novartis Pharmaceuticals Corporation | CANYON CITY EYECARE | $2,858 | A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-MASKED, MULTI-CENTER, DOSE-RANGING STUDY TO EVALUATE THE SAFETY, AND EFFICACY O | 2021 |
| 2021-01-18 | Novartis Pharmaceuticals Corporation | MILTON HOM OD | $105,554 | A RANDOMIZED, DOUBLE-MASKED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ECF843 VS VEHICLE IN SUBJECTS WITH | 2021 |
| 2020-11-19 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $700 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-11-19 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $327 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-08-25 | Novartis Pharmaceuticals Corporation | MILTON HOM OD | $1,532 | A RANDOMIZED, DOUBLE-MASKED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ECF843 VS VEHICLE IN SUBJECTS WITH | 2020 |
| 2020-06-25 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $86 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-05-28 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $86 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-05-26 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $86 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-05-26 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $315 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-05-26 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $86 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-05-26 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $371 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-04-21 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $14,440 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2020 |
| 2020-02-25 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $534 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2020-01-23 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $18,720 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2020 |
| 2020-01-21 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $700 | A PHASE 3, MULTICENTER, DOUBLE-MASKED, RANDOMIZED, VEHICLE-CONTROLLED, PARALLEL- GROUP STUDY EVALUATING THE SAFETY AND E | 2020 |
| 2020-01-07 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $700 | A MULTICENTER, SINGLE-MASKED, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO NOVEL ARTIFICIAL TEAR FORMULATI | 2020 |
| 2019-12-10 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $503 | A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel- Group Study Evaluating the Safety and E | 2019 |
| 2019-11-14 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $6,600 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
| 2019-10-15 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $315 | A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel- Group Study Evaluating the Safety and E | 2019 |
| 2019-10-01 | Allergan, Inc. | COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP | $700 | A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel- Group Study Evaluating the Safety and E | 2019 |
| 2019-09-04 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $7,560 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
| 2019-06-12 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $18,900 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
| 2019-05-07 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $22,680 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
| 2019-04-29 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $3,350 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
| 2019-04-10 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $3,780 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
| 2019-03-28 | Allergan, Inc. | MILTON M HOM OD FAAO | $2,000 | A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel- Group Study Evaluating the Safety and E | 2019 |
| 2019-03-28 | Allergan, Inc. | MILTON M HOM OD FAAO | $5,500 | A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel- Group Study Evaluating the Safety and E | 2019 |
| 2019-03-28 | Allergan, Inc. | MILTON M HOM OD FAAO | $1,000 | A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel- Group Study Evaluating the Safety and E | 2019 |
| 2019-03-05 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $3,350 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
| 2019-01-16 | Kala Pharmaceuticals, Inc. | MILTON M HOM OD FAAO | $3,780 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Azusa, CA, county Los Angeles County, CA, state California; placed by its city name.
| Measure | Place (city or town) Azusa, CA | County Los Angeles County, CA | State California |
|---|---|---|---|
| Population B01003 | 49,031 | 9,808,667 | 39,287,377 |
| Population, 2020 census P1 | 50,000 | 10,014,009 | 39,538,223 |
| Median age B01002 | 34.4 | 38.2 | 37.9 |
| Under 18 B01001 | 21.1% | 20.6% | 22.0% |
| 65 and over B01001 | 12.7% | 15.2% | 15.7% |
| Households B11001 | 14,870 | 3,416,449 | 13,548,091 |
| Foreign born B05002 | 32.1% | 33.4% | 27.0% |
| Median household income B19013 | $90,721 | $90,112 | $99,122 |
| Median family income B19113 | $97,749 | $101,573 | $113,346 |
| Per capita income B19301 | $33,977 | $45,792 | $49,513 |
| Poverty rate B17001 | 13.2% | 13.7% | 12.0% |
| Unemployment rate B23025 | 6.1% | 7.3% | 6.6% |
| Civilian labor force B23025 | 26,497 | 5,200,656 | 20,068,466 |
| Mean commute (minutes) B08013 | 30.1 | 30.4 | 28.7 |
| Bachelor's degree or higher B15003 | 27.3% | 36.0% | 37.1% |
| Housing units B25001 | 15,580 | 3,650,466 | 14,644,735 |
| Owner-occupied B25003 | 55.2% | 45.9% | 55.9% |
| Renters B25003 | 44.8% | 54.1% | 44.1% |
| Median home value B25077 | $641,400 | $834,200 | $734,700 |
| Median gross rent B25064 | $1,887 | $1,954 | $2,036 |
| White, not Hispanic B03002 | 13.8% | 24.7% | 33.8% |
| Black B03002 | 2.5% | 7.4% | 5.2% |
| Hispanic or Latino B03002 | 65.4% | 48.4% | 40.2% |
| Asian B03002 | 15.0% | 14.9% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Azusa, CA.
Comments